Colossal CEO Explains Why Its De-Extinction Work Won’t Include Dinosaurs

Colossal Biosciences is pursuing projects involving the dodo and woolly mammoth, but dinosaurs are outside its de-extinction plans. CEO Ben Lamm has pointed to the lack of usable dinosaur DNA as a central obstacle. The distinction reflects the biological evidence available to researchers, not a change in the company’s announced targets. TechCrunch’s report on Lamm’s remarks said Colossal’s other targets include the thylacine, also known as the Tasmanian tiger.